Nongshim: Steady Profit Recovery, Low Multiples Versus Own History and Some Peers

Thesis

The data supports a picture of a slow-growing, financially conservative food company whose profitability has improved since 2022. Operating margin moved from 3.6% in 2022 to 6.2% in 2023, dipped to 4.7% in 2024, and recovered to 5.2% in 2025 and 5.9% on a trailing basis through H1 2026. Revenue growth has slowed to low single digits (2.2% in 2025, 0.8% in 2024).

The stock trades below book value (P/B 0.8) and at a lower P/E than the 15.5x recorded at the end of 2025. However, ROE is only 6.9%, which may help explain why the market is not paying a higher multiple. Investor flow, foreign ownership and short-balance data are not available, so the data cannot show who has been buying or selling.

Business overview

Nongshim is a KOSPI-listed Food & Beverage company founded on 1965-09-18 and listed on 1976-06-30, with 6,082,642 listed shares and CEO 조용철. Trailing revenue is ₩3.64T. Revenue grew from ₩2.66T in 2021 to ₩3.51T in 2025, with the fastest growth in 2022 (17.5%) and 2023 (9.0%). Recent news headlines mention a new product launch (Gambas Jjapaguetti) and competition with Samyang Foods in black-noodle products abroad, but the data gives no sales figures for them.

Financial analysis

All figures below come from filed financial statements (DART). Trailing revenue through H1 2026 is ₩3.64T, operating income ₩214.4B and net income ₩196.9B, giving an operating margin of 5.9% and a net margin of 5.4%. Annual operating income was ₩183.9B in 2025, ₩163.1B in 2024 and ₩212.1B in 2023. Net income was ₩170.1B in 2025.

ROE is 6.9% trailing versus 6.2% in 2025 and 7.3% in 2023. The balance sheet is light on debt: liabilities to equity of 36.9%, cash of ₩219.4B against borrowings of only ₩27.5B. Free cash flow is ₩197.2B on a trailing basis, close to net income.

Valuation

At ₩401,000 the stock trades at P/E 12.4x, P/B 0.8x, P/S 0.7x and a dividend yield of 1.4%. Enterprise value is ₩2.25T; EV/EBITDA is not available. The year-end 2025 multiples were P/E 15.5x and P/B 0.9x, so current multiples are lower; earlier year-end multiples are not available.

Among peers with data, Orion trades at P/E 10.0x and P/B 1.0x, Samyang Foods at P/E 18.5x and P/B 5.9x, and CJ Cheiljedang at P/B 0.4x (P/E not available). Otoki and Lotte Wellfood have no multiples in the data. Nongshim sits within the peer range. The share price is ₩401,000 versus a 52-week range of ₩319,000 to ₩480,500, and returns are -3.3% over one month, 12.6% over three months and -10.1% over one year.

Catalysts

• A corporate value-up plan was filed on 2026-07-28, which may affect how shareholder returns and capital allocation are viewed.
• The H1 2026 half-year report filed on 2026-08-14 showed trailing operating margin of 5.9%, and the next results will show whether the improvement continues.
• Three 5%+ holding reports were filed between 2026-09-30 and 2026-10-07, indicating changes in major shareholdings, though the data does not give details.
• A treasury share sale decision was amended on 2026-09-03, along with a related result report, which relates to the company's own share holdings.
• October 2026 news reports on the Gambas Jjapaguetti launch and competition in black noodles abroad point to product activity, without sales data.

Risks

• Revenue growth has slowed to 2.2% in 2025 and 0.8% in 2024, so profit gains have relied on margins rather than sales growth.
• Operating margin has been volatile, falling from 6.2% in 2023 to 4.7% in 2024, so recent gains could reverse.
• ROE of 6.9% is modest, which may limit the support for higher valuation multiples.
• The share price is down 10.1% over one year and 1.7% below... the 52-week high is ₩480,500, about 16.6% above the current price, showing sensitivity to sentiment.
• Investor flow, foreign ownership and short-interest data are not available, so shifts in market positioning cannot be assessed.

Closing view

The filed numbers show a financially sound company with little debt, ample cash, free cash flow near net income and margins that have recovered since 2022. Against that, sales growth is slow, ROE is below 7%, and margins have swung from year to year. Current multiples of 12.4x earnings and 0.8x book are below the year-end 2025 levels and fall inside the peer range, but the data lacks flow and positioning information and offers no basis for judging future results. The evidence is mixed rather than conclusive.

Model estimate of fair value

The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).

Report history

1. Oct 13, 2026InitiationNongshim: Steady Profit Recovery, Low Multiples Versus Own History and Some Peers